Clinical Trials Logo

Clinical Trial Summary

People with central lobe epilepsy (CLE), with seizures arising from the primary sensorimotor cortex, typically show a high rate of convulsive seizures that do not respond to anti-epileptic drugs, but have a large impact on quality of life. They often seek surgical relief, but since the area contains the body's indispensable sensorimotor representation, CLE surgery will lead to permanent functional deficits. Cortical stimulation case studies in CLE have shown seizure frequency reduction of more than 90%, but in our experience, stimuli in the central lobe can hardly be applied without interfering with motor function.

The investigators propose cortical electrical stimulation therapy of a conceptually novel type. The investigators systematically determine individual stimulation settings, stimulation site and a seizure detection algorithm. In REC2Stim (Rational Extra-eloquent Closed-loop Cortical Stimulation), at the start of a seizure, a train of electric pulses is delivered to a nearby extra-eloquent area connected with the epileptogenic area within the sensorimotor cortex. Success will constitute a therapeutic modality for pharmaco-resistant patients with an epileptic focus in eloquent areas.


Clinical Trial Description

The investigators will include ten patients with CLE, aged 16 years and older, in whom pre-surgical chronic intracranial EEG monitoring has revealed a seizure onset in the primary sensorimotor cortex. Patients should have on average at least two seizures per day.

Clinical intracranial EEG monitoring (normally 7-10 days) will be extended with two extra monitoring days, for systematic testing of different stimulation settings and their effect on interictal epileptiform EEG activity (as a surrogate marker for ictal epileptiform activity), from which site and parameters for chronic stimulation will be determined.

Upon removal of the clinically implanted electrodes, a neurostimulator with sensing capabilities, Activa PC+S, will be implanted and attached to two subdural leads with electrodes covering the predefined stimulation site and the eloquent epileptogenic area.

During a data collection phase, stimulation-free data will then be collected to train the seizure detection algorithm up to at least 50% sensitivity.

Finally, the REC2Stim phase will be started, in which cortical stimulation is applied when seizure activity is detected. Study participation is one year. When REC2Stim turns out effective in month 10 and 11 after implantation of the neurostimulator, 2 weeks of sham stimulation will follow in month 12. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04158531
Study type Interventional
Source UMC Utrecht
Contact Frans Leijten, MD, PhD
Phone +31 88 75 579 83
Email F.S.S.leijten@umcutrecht.nl
Status Recruiting
Phase N/A
Start date November 4, 2019
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT03014752 - Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy Phase 2/Phase 3
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Completed NCT05503511 - Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects Phase 1
Enrolling by invitation NCT04286776 - Memory Retrieval and Encoding Investigated by Neural Stimulation N/A
Completed NCT04763070 - Ciprofloxacin in Drug-resistant Epilepsy N/A
Completed NCT03403907 - The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients N/A
Recruiting NCT03289572 - Microgrid II - Electrocorticography Signals for Human Hand Prosthetics
Enrolling by invitation NCT05332990 - Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
Recruiting NCT04325360 - Effects of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Refractory Epilepsy N/A
Active, not recruiting NCT05727943 - Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study Phase 2
Recruiting NCT04649008 - Localizing Epileptic Networks Using MRI and iEEG Early Phase 1
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Completed NCT03646240 - ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE) Phase 1
Recruiting NCT03857074 - Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy N/A
Enrolling by invitation NCT03702127 - TMS - Intracranial Electrodes N/A
Recruiting NCT05015868 - Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies N/A
Enrolling by invitation NCT06138808 - 5-SENSE Score Validation Study
Not yet recruiting NCT03741192 - Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs N/A
Enrolling by invitation NCT05248269 - Thermocoagulation in Drug Resistant Focal Epilepsy N/A
Completed NCT04399954 - Evaluation of Ketoflo N/A